Bank of New York Mellon Corp Takes Position in Merit Medical Systems, Inc. $MMSI

Key Points

• Bank of New York Mellon acquired 410,578 shares of Merit Medical Systems worth approximately $28.5 million, giving it a 0.69% stake. Institutional investors collectively own 99.66% of the company.
• Merit Medical reported quarterly EPS of $1.19, exceeding estimates by $0.23, while revenue rose 9.5% year over year to $418.84 million. The company issued fiscal 2026 EPS guidance of $4.25–$4.35.
• Analysts remain broadly positive, with a “Moderate Buy” consensus and an average price target of $100, compared with the stock’s reported price of $90.49.

Bank of New York Mellon Corp bought a new position in Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 410,578 shares of the medical instruments supplier's stock, valued at approximately $28,470,000. Bank of New York Mellon Corp owned about 0.69% of Merit Medical Systems as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in MMSI. State Street Corp boosted its holdings in shares of Merit Medical Systems by 1.5% during the 4th quarter. State Street Corp now owns 2,231,048 shares of the medical instruments supplier's stock worth $196,645,000 after buying an additional 32,459 shares during the period. Conestoga Capital Advisors LLC lifted its position in Merit Medical Systems by 3.9% during the 1st quarter. Conestoga Capital Advisors LLC now owns 2,167,513 shares of the medical instruments supplier's stock worth $149,407,000 after acquiring an additional 81,030 shares during the last quarter. Fuller & Thaler Asset Management Inc. boosted its holdings in Merit Medical Systems by 12.7% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 2,077,796 shares of the medical instruments supplier's stock valued at $183,137,000 after acquiring an additional 234,682 shares during the period. Wellington Management Group LLP grew its position in shares of Merit Medical Systems by 7.0% in the fourth quarter. Wellington Management Group LLP now owns 1,327,013 shares of the medical instruments supplier's stock valued at $116,963,000 after purchasing an additional 86,504 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in shares of Merit Medical Systems by 1.0% in the first quarter. Dimensional Fund Advisors LP now owns 1,237,298 shares of the medical instruments supplier's stock worth $85,287,000 after purchasing an additional 12,285 shares during the period. Institutional investors own 99.66% of the company's stock.

Merit Medical Systems Stock Up 1.1%

MMSI opened at $90.49 on Friday. The company has a market capitalization of $5.40 billion, a P/E ratio of 37.39, a P/E/G ratio of 2.26 and a beta of 0.49. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.20 and a quick ratio of 2.79. The firm's fifty day moving average price is $79.77 and its two-hundred day moving average price is $72.91. Merit Medical Systems, Inc. has a fifty-two week low of $59.74 and a fifty-two week high of $94.75.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last issued its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.23. The business had revenue of $418.84 million for the quarter, compared to analyst estimates of $405.25 million. Merit Medical Systems had a net margin of 9.22% and a return on equity of 13.75%. The firm's revenue was up 9.5% on a year-over-year basis. During the same period in the previous year, the business earned $1.01 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. On average, analysts anticipate that Merit Medical Systems, Inc. will post 3.84 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the company. Canaccord Genuity Group boosted their price objective on Merit Medical Systems from $85.00 to $94.00 and gave the stock a "buy" rating in a research report on Friday, July 31st. Barrington Research set a $114.00 price target on Merit Medical Systems in a research report on Friday, July 31st. Raymond James Financial reiterated an "outperform" rating and set a $100.00 price target on shares of Merit Medical Systems in a report on Friday, July 31st. Wells Fargo & Company increased their price objective on Merit Medical Systems from $74.00 to $83.00 and gave the company an "equal weight" rating in a research report on Friday, July 31st. Finally, Needham & Company LLC raised their price objective on shares of Merit Medical Systems from $90.00 to $101.00 and gave the stock a "buy" rating in a research note on Friday, July 31st. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $100.00.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company's product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source